-
Exocrine Pancreas Cancer and Thromboembolic Events: A Systematic Literature Review
Does antithrombotic therapy improve cancer-related outcomes among patients with pancreatic cancer? The current review examines this question and others in a review of thromboembolism among patients with pancreatic cancer.
July 10, 2012
-
Liver-Directed Therapies in Patients With Advanced Neuroendocrine Tumors
What are the best treatment options for liver metastases among patients with neuroendocrine tumors? The current review provides evidence-based answers.
June 04, 2012
-
Update on Safety of ESAs in Cancer-Induced Anemia
Should physicians use erythropoiesis-stimulating agents in patients with cancer? Dr. Glaspy addresses this question.
May 07, 2012
-
Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting
What is the role of corticosteroids in the modern treatment of chemotherapy-induced nausea and vomiting? The current review provides answers.
April 09, 2012
-
Unanswered Questions About Margin Recommendations for Primary Cutaneous Melanoma
When should physicians pursue wider surgical margins in cases of melanoma? The current review provides evidence-based answers.
March 05, 2012
-
Challenges in the Management of Older Patients With Colon Cancer
Should physicians routinely employ surgery and chemotherapy in the management of colon cancer among older adults? The current review provides answers.
February 06, 2012
-
How to Choose Frontline Therapy for Chronic Myelogenous Leukemia: So Many Drugs, Not So Many Patients
Three tyrosine kinase inhibitors are now available to treat chronic myelogenous leukemia and each may play a role in frontline therapy, as the newer agents may achieve earlier therapeutic milestones.
January 06, 2012
-
Management of Neuroendocrine Tumors of Unknown Origin
When the location of the primary malignancy cannot be found, treatment of neuroendocrine tumors is often based on the tumor grade and level of differentiation.
December 09, 2011
-
Biomarker Use in Colorectal Cancer Therapy
Biomarkers for colorectal cancers can help guide clinical management and may allow enrichment, stratification, and identification of novel therapeutic targets in drug development.
November 07, 2011
-
The Impact of Genomics on the Management of Myeloma
Genomics has an increasingly important role in the management of patients with multiple myeloma. The current review describes this emerging field.
October 07, 2011
-
Selecting Targeted Therapies for Patients With Renal Cell Carcinoma
Treatment choice for advanced RCC can be guided by the disease setting, histology, and patient characteristics, comorbidities, and preference, on the basis of available evidence.
September 07, 2011
-
Biosimilars: Are They Ready for Primetime in the United States?
"Biosimilars" are alternative versions of existing biologic agents. This study examines the quality of biosimilars, and looks at the challenges in assuring similar results between biologic agents and biosimilars.
August 04, 2011
-
Risk Assessment and Prophylaxis for VTE in Cancer Patients
A review describes recent and ongoing studies of venous thromboembolism (VTE) risk assessment and prophylaxis in patients with cancer.
July 05, 2011
-
Current Recommendations for Systemic Therapy of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
What are the best practices for treatment of patients with recurrent and/or metastatic head and neck cancer that cannot be cured with surgery or radiation therapy? The current review examines the state-of-the-art.
June 01, 2011
-
Role of Routine Imaging in Lymphoma
What should physicians consider when ordering imaging studies for the surveillance of patients who have completed treatment for lymphoma? The current review explores this complicated issue.
May 03, 2011
-
Multigene Sets for Clinical Application in Glioma
Can molecular genetic analysis help physicians take better care of patients with glioma? The current review describes the state-of-the-art.
April 01, 2011
-
Identifying Older Patients With Acute Myeloid Leukemia Who May Be Candidates for Reduced-Intensity Hematopoietic Cell Transplantation
Is it safe to recommend reduced-intensity hematopoietic cell transplantation for older patients? The current review answers this important question.
March 07, 2011
-
Inflammatory Breast Cancer
New treatments can improve the survival outcomes for women with inflammatory breast cancer. This review highlights the best practice in the diagnosis and management of inflammatory breast cancer.
February 07, 2011
-
The Role of Iron Chelation Therapy for Patients With Myelodysplastic Syndromes
Can iron chelation therapy help patients with myelodysplastic syndromes, or is it more likely to hurt? The current review examines this controversial issue.
January 14, 2011
-
The Emerging Use of IMRT for Treatment of Cervical Cancer
Intensity-modulated radiation therapy may improve the therapeutic ratio for cervical cancer because it can escalate dose to cancer targets while sparing adjacent healthy tissue.
December 10, 2010
